We are live on ! Find out more
TA

TFG Advisers Portfolio holdings

AUM $292M
1-Year Est. Return 15.01%
This Fund
S&P 500
This Quarter Est. Return
+11.56%
1 Year Est. Return
+15.01%
3 Year Est. Return
+61.81%
5 Year Est. Return
+108.38%
10 Year Est. Return
AUM
$229M
AUM Growth
+$22.9M
Cap. Flow
+$1.92M
Cap. Flow %
0.84%
Top 10 Hldgs %
28.07%
Holding
206
New
11
Increased
96
Reduced
93
Closed

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$773K
2
CL icon
Colgate-Palmolive
CL
+$491K
3
WSM icon
Williams-Sonoma
WSM
+$277K
4
TGT icon
Target
TGT
+$264K
5
APD icon
Air Products & Chemicals
APD
+$239K

Sector Composition

Rank Sector Weight
1 Technology 20.19%
2 Industrials 9.3%
3 Consumer Discretionary 7.35%
4 Healthcare 7.15%
5 Consumer Staples 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALGN icon
151
Align Technology
ALGN
$12.9B
$336K 0.15%
512
-56
-10% -$36K
VGK icon
152
Vanguard FTSE Europe ETF
VGK
$30.1B
$332K 0.14%
4,873
+45
+0.9% +$3.05K
HLT icon
153
Hilton Worldwide
HLT
$72.4B
$330K 0.14%
2,115
IWS icon
154
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$314K 0.14%
2,569
+30
+1% +$3.58K
RCS
155
PIMCO Strategic Income Fund
RCS
$242M
$313K 0.14%
46,071
-7,941
-15% -$57K
IWO icon
156
iShares Russell 2000 Growth ETF
IWO
$14.1B
$312K 0.14%
1,065
+14
+1% +$4.22K
PFE icon
157
Pfizer
PFE
$143B
$310K 0.14%
5,244
-22
-0.4% -$1.09K
CSX icon
158
CSX Corp
CSX
$94B
$304K 0.13%
8,074
-352
-4% -$12.4K
GILD icon
159
Gilead Sciences
GILD
$165B
$301K 0.13%
4,146
-415
-9% -$28.6K
APH icon
160
Amphenol
APH
$185B
$294K 0.13%
6,720
+8
+0.1% +$324
FXH icon
161
First Trust Health Care AlphaDEX Fund
FXH
$1.05B
$294K 0.13%
2,367
IVV icon
162
iShares Core S&P 500 ETF
IVV
$858B
$294K 0.13%
616
-9
-1% -$4.15K
LMBS icon
163
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.35B
$288K 0.13%
5,759
-360
-6% -$18.1K
PTY icon
164
PIMCO Corporate & Income Opportunity Fund
PTY
$2.46B
$288K 0.13%
17,411
+545
+3% +$9.7K
FGD icon
165
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.54B
$287K 0.13%
11,427
-276
-2% -$7K
RSPH icon
166
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$773M
$287K 0.13%
8,960
-50
-0.6% -$1.52K
SYLD icon
167
Cambria Shareholder Yield ETF
SYLD
$1B
$283K 0.12%
4,380
+12
+0.3% +$768
TIP icon
168
iShares TIPS Bond ETF
TIP
$14.5B
$281K 0.12%
2,173
+281
+15% +$36.2K
XSOE icon
169
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$1.93B
$279K 0.12%
7,569
-3,755
-33% -$141K
DUK icon
170
Duke Energy
DUK
$101B
$276K 0.12%
2,630
-437
-14% -$44.3K
CARR icon
171
Carrier Global
CARR
$49.8B
$275K 0.12%
5,079
+652
+15% +$35.2K
CHY
172
Calamos Convertible and High Income Fund
CHY
$978M
$272K 0.12%
16,812
+5,129
+44% +$83.2K
BSV icon
173
Vanguard Short-Term Bond ETF
BSV
$44.7B
$271K 0.12%
3,356
-19
-0.6% -$1.54K
DEM icon
174
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.8B
$268K 0.12%
6,189
+221
+4% +$9.62K
VOT icon
175
Vanguard Mid-Cap Growth ETF
VOT
$18.9B
$268K 0.12%
1,051
+9
+0.9% +$2.27K

Similar funds

TFG Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, TFG Advisers held 206 positions worth $229M, up 11% from $206M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

TFG Advisers's Q4 2021 filing shows 11 new, 96 increased and 93 reduced positions. Its largest new stake was Eli Lilly: 3,050 shares worth $842K. The largest sale was AT&T, an estimated $781K.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • TFG Advisers's largest Q4 2021 buy was Eli Lilly: 3,050 shares worth $842K.
  • TFG Advisers added most to First Trust Senior Floating Rate Income Fund II in Q4 2021, an estimated $229K increase.
  • TFG Advisers's biggest Q4 2021 reduction was AT&T, cutting an estimated $781K.
  • TFG Advisers's ten largest holdings make up 28% of its $229M portfolio in Q4 2021.
  • TFG Advisers opened 11 new positions and closed 0 in Q4 2021.
  • TFG Advisers's portfolio value rose 11% quarter-over-quarter to $229M.

Based on TFG Advisers's 13F filing for Q4 2021, filed 1 Feb 2022.